Jiangsu Pengyao Pharmaceutical Co., Ltd. is headquartered in Yixing City, Jiangsu Province. It is a comprehensive professional preparation enterprise in Jiangsu Province. The company has a registered capital of US$1.62 million, currently has more than 200 employees, more than 100 employees of various professional titles, 1 doctoral student, and 5 master's students. It has a professional management team that is strong and enterprising.

The company has more than 200 specifications of product groups in the fields of antibiotics, digestive system drugs, circulatory system drugs, antitumor drugs, antipyretic analgesics, health products, etc., and nearly 90 products have entered the national new version of the basic medicine catalog. The main dosage forms include tablets, capsules, solutions, pills, suspensions, pills, soft capsules, raw materials, etc. The company's main products include calamine lotion, carbamazepine tablets, amlodipine benzenesulfonate tablets, shark hepatol tablets, omeprazole enteric capsules, etc. The products are best sold in Beijing, Tianjin, Jiangsu, Guangdong, Hunan, Hubei Many provinces, cities and districts such as Shandong, Anhui, and Shaanxi have established a good reputation and customer base in the industry. Based on the existing product technology, the company will strengthen the development of subsequent new products and gradually become the main force in the field of comprehensive professional preparations.

The company currently produces 5 billion tablets/year, 500 million capsules/year, 50 million bags/year, 10 million bottles/year, external medicines, 200 million soft capsules/year, and 500 kg of drop pills. scale. After implementation, the second phase of the company's under construction is expected to add 2.5 billion tablets/year, 250 million capsules/year, 100 million small-volume injections/year, and 50 million bags of Chinese pills (extracted from the front road)/year Annual, 6 million catheter sets/year, and 4 million catheter packs/year, will greatly increase the company's production capacity and expand the company's product line, which will help enhance the company's market competitiveness.

The company established the Pengyao New Drug Innovation Center in 2020, which will face new demands for healthy social development and new situations of aging society. The center will run through the health culture of traditional Chinese and Western medicine, integrate the scientific health concepts of traditional Chinese and Western medicine, carry out the research, development and application of traditional Chinese medicine, chemical drugs, biological drugs, special medical foods and health products, learn social health theories, and improve social health services. Based on the introduction and self-development, we will gradually form our own advantages in the fields of geriatric diseases, metabolic regulation, neuropsychiatric, anti-infection, rare diseases, and anti-tumors, and establish corresponding workstations for subsequent development and cultivation and reserve Leading talents, building a health industry base, and making due contributions to promoting my country's new drugs and health industry.

The company adheres to the corporate philosophy of "quality first and pursuit of human health", carries forward the corporate spirit of "being virtuous and carrying things with diligence and strength", and follows the "creating brand with quality, surviving with integrity, pursuing efficiency with management, and pursuing technology. Development” business purpose. The company has been rated as a high-tech enterprise for many years and is a contract-abiding and credit-oriented enterprise in Jiangsu Province.